Nifedipine Improves the Ketogenic Diet Effect on Insulin-Resistance-Induced Cognitive Dysfunction in Rats.
Nancy M Abdel-KareemShimaa M ElshazlyMay A Abd El FattahAfaf A AldahishSawsan A ZaitoneSahar K AliEnas A Abd El-HaleimPublished in: Pharmaceuticals (Basel, Switzerland) (2024)
Insulin resistance, induced by high fructose consumption, affects cognitive function negatively. Nifedipine may be suggested for neurological disorders. This study aimed to assess the effect of nifedipine with either a normal diet (ND) or a ketogenic diet (KD) in cognitive dysfunction. Male Wistar rats received 10% fructose in drinking water for 8 weeks to induce insulin resistance. Rats received nifedipine (5.2 mg/kg/day; p.o.) later with ND or KD for an additional five weeks. One and two-way ANOVAs were used in analyzing the data. Reversion to the ND improved insulin resistance and lipid profile, besides brain-derived neurotrophic factor (BDNF), glycogen synthase kinase-3 beta (GSK3β), and insulin-degrading enzyme (IDE) levels. Rats fed KD alone and those that received nifedipine with KD did not show similar improvement in the previously mentioned parameters as the ND group. However, nifedipine-ND rats showed improvement in cognitive behavior and insulin resistance. Treatment with nifedipine-KD ameliorated GSK3β, amyloid β (Aβ), and tau protein levels. As the nifedipine-KD combination succeeded in diminishing the accumulated Aβ and tau protein, KD may be used for a while due to its side effects, then nifedipine treatment could be continued with an ND. This conclusion is based on the finding that this combination mitigated insulin resistance with the associated improved behavior.
Keyphrases
- insulin resistance
- adipose tissue
- type diabetes
- metabolic syndrome
- high fat diet
- drinking water
- polycystic ovary syndrome
- skeletal muscle
- high fat diet induced
- physical activity
- signaling pathway
- cell proliferation
- health risk
- cerebrospinal fluid
- protein protein
- risk assessment
- electronic health record
- brain injury
- oxidative stress
- tyrosine kinase
- cerebral ischemia
- health risk assessment